TFF Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
TFF Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2021 to Q1 2024.
  • TFF Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $901K.
  • TFF Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.01M, a 57.3% decline from 2022.
  • TFF Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.8M, a 59.3% decline from 2021.
  • TFF Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $28.9M, a 15.6% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $901K +$919K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 -$17.9K* Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2021 $28.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.